共 80 条
[1]
Hirode G(2019)Increasing clinical and economic burden of nonalcoholic fatty liver disease among hospitalized adults in the United States J Clin Gastroenterol 10 1097-84
[2]
Vittingho E(2016)Global epidemiology of nonalcoholic fatty liver disease – Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology. 64 73-501
[3]
Wong RJ(2005)Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies Obes Surg 15 497-1030
[4]
Younossi ZM(2017)Individual patients data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis J Hepatol 66 1022-253
[5]
Koenig AB(2012)Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan (R): Validation in chronic hepatitis C J Viral Hepat 19 244-164
[6]
Abdelatif D(2016)Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases J Clin Ultrasound 29 25-2940
[7]
Fazel Y(2015)Effect of diffuse fatty infiltration of the liver on hepatic artery resistance index J Clin Ultrasound 33 95. 20-155
[8]
Henry L(2016)Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients J Pediatr 173 160-912
[9]
Wymer M(2006)The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population BMC Gastroenterol 6 33-TC10
[10]
Janiec DJ(2018)Association between body mass index and fatty liver risk: A dose-response analysis Sci Rep 8 2936-TC10